Dimensional Fund Advisors Ltd. : Form 8.3 - Udg Healthcare Plc - Ordinary Shares

 
TIDMUDG 
 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

   1.    KEY INFORMATION 
 
Name of person dealing      Dimensional Fund Advisors 
 (Note 1)                    Ltd. ("Dimensional"), in 
                             its capacity as investment 
                             manager and on behalf its 
                             affiliates who are also 
                             investment managers. Dimensional 
                             and its affiliates expressly 
                             disclaim beneficial ownership 
                             of the shares described 
                             in this form 8.3 
--------------------------  --------------------------------- 
Company dealt in            UDG HEALTHCARE PLC 
--------------------------  --------------------------------- 
Class of relevant security  EUR0.05 ordinary shares 
 to which the dealings 
 being disclosed relate 
 (Note 2) 
--------------------------  --------------------------------- 
Date of dealing             12 August 2021 
--------------------------  --------------------------------- 
 
   2.    INTERESTS AND SHORT POSITIONS 
   (a)    Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) 
 
                                       Long             Short 
---------------------------  -------------------  ------------- 
                             Number        (%)    Number    (%) 
---------------------------  ------------  -----  --------  --- 
(1) Relevant securities        2,765,761 (1.10%) 
---------------------------  -------------------  ------------- 
(2) Derivatives (other 
 than options) 
---------------------------  -------------------  ------------- 
(3) Options and agreements 
 to purchase/sell 
---------------------------  -------------------  ------------- 
Total                          2,765,761 (1.10%) 
---------------------------  -------------------  ------------- 
 

Please note there were net transfers in of 172 shares.

   (b)    Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) 
 
Class of relevant security:          Long          Short 
---------------------------  --------------  --------------- 
                             Number     (%)  Number      (%) 
---------------------------  -------    ---  --------    --- 
(1) Relevant securities 
---------------------------  --------------  --------------- 
 
 (2) Derivatives (other 
 than options) 
---------------------------  --------------  --------------- 
 
 (3) Options and agreements 
 to purchase/sell 
---------------------------  --------------  --------------- 
Total 
---------------------------  --------------  --------------- 
 

Ap20

   1.    DEALINGS (Note 4) 
   (a)    Purchases and sales 
 
 
 Purchase/sale   Number of relevant securities   Price per unit 
                                                 (Note 5) 
--------------  ------------------------------  --------------- 
Sale            17,220                          GBP 10.7894 
--------------  ------------------------------  --------------- 
 
   (b)    Derivatives transactions (other than options transactions) 
 
Product    Nature of transaction  Number of relevant  Price per 
 name,      (Note 6)               securities          unit 
 e.g. CFD                          (Note 7)            (Note 5) 
---------  ---------------------  ------------------  --------- 
 
 
   (c)    Options transactions in respect of existing relevant securities 
   (i)    Writing, selling, purchasing or varying 
 
Product     Writing,      Number of       Exercise  Type,            Expiry  Option 
 name,       selling,      securities      price     e.g. American,   date    money paid/received 
 e.g. call   purchasing,   to which                  European                 per unit 
 option      varying       the option                etc.                     (Note 5) 
             etc.          relates (Note 
                           7) 
----------  ------------  --------------  --------  ---------------  ------  -------------------- 
 
 
   (ii)    Exercising 
 
Product name,            Number of securities      Exercise price 
 e.g. call option                                   per unit (Note 
                                                    5) 
-----------------  --------------------------  ------------------- 
 
 
   (d)    Other dealings (including transactions in respect of new securities) (Note 4) 
 
Nature of transaction        Details      Price per unit 
 (Note 8)                                  (if applicable) 
                                           (Note 5) 
---------------------  -------------  -------------------- 
                                      N/A 
---------------------  -------------  -------------------- 
 

Ap21

   2.    OTHER INFORMATION 

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 attached? (Note 9) NO

 
Date of disclosure             13 August 2021 
----------------------------  ---------------- 
Contact name                    Thomas Hone 
----------------------------  ---------------- 
Telephone number              [phone] 
----------------------------  ---------------- 
If a connected EFM, name      N/A 
 of offeree/offeror with 
 which connected 
----------------------------  ---------------- 
If a connected EFM, state     N/A 
 nature of connection (Note 
 10) 
----------------------------  ---------------- 
 
 
 

(END) Dow Jones Newswires

August 13, 2021 07:16 ET (11:16 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.